Skip to main content
. Author manuscript; available in PMC: 2019 Sep 28.
Published in final edited form as: Curr Allergy Asthma Rep. 2019 Sep 5;19(10):48. doi: 10.1007/s11882-019-0876-0

Fig. 1.

Fig. 1

Multimodal action of TAS2Rs for controlling asthma symptoms. Asthma is marked by distinct yet interlinked pathologies such as airway inflammation, hyperresponsiveness, and remodeling and excessive mucus secretion. Owing to their expression and their ability to regulate physiological outcomes in various cell types important to asthma pathology, TAS2Rs have emerged as a promising candidate for the development of comprehensive anti-asthma therapy